{"ads":[{"pos":1,"asin":"0857114328","type":"organic_also_viewed","price":206.59,"title":"British national formulary: 84: September 2022 - March 2023","images":["https:\/\/images-eu.ssl-images-amazon.com\/images\/I\/61hnCFZ-d9L._AC_UL160_SR160,160_.jpg"],"rating":4.7,"location":"carousel","price_upper":206.59,"reviews_count":40,"is_prime_eligible":false}],"url":"https:\/\/www.amazon.ae\/British-National-Formulary-March-2023\/dp\/0857114581\/ref=mp_s_a_1_1?crid=SOODLUHMRXLT&keywords=bnf&qid=1693950749&sprefix=bnf,aps,520&sr=8-1","asin":"0857114581","page":1,"price":231.9,"stock":"In Stock","title":"BNF 85 (British National Formulary) March 2023","coupon":"","images":["https:\/\/m.media-amazon.com\/images\/I\/61PWf+6i5PL.jpg"],"rating":4.6,"category":[{"ladder":[{"url":"\/b\/ref=dp_bc_aui_C_1?ie=UTF8&node=11497688031","name":"Books"},{"url":"\/b\/ref=dp_bc_aui_C_2?ie=UTF8&node=12379700031","name":"Medicine & Nursing"},{"url":"\/b\/ref=dp_bc_aui_C_3?ie=UTF8&node=12379955031","name":"Administration & Medicine Economics"}]}],"currency":"AED","delivery":[{"date":{"by":"Tomorrow, 7 September","from":null},"type":"FREE Returns  \n                    \n    Easy and Hassle Free Returns    You can return this item for FREE within the allowed return period for any reason and without any shipping charges. The item must be returned in new and unused condition.      Read more about the return period and Amazon's return policy.         How to return this item?     Go to \"Orders\" to start the return  Select you refund method and pickup date  Keep the item ready for pickup in it's original packaging"}],"_warnings":["Could not parse lightning deal."],"deal_type":"","page_type":"Product","price_sns":0,"variation":[{"asin":"0857114581","selected":true,"dimensions":{"Format":"Paperback"}}],"has_videos":false,"sales_rank":[{"rank":8901,"ladder":[{"url":"\/gp\/bestsellers\/books\/ref=pd_zg_ts_books","name":"Books"}]},{"rank":4,"ladder":[{"url":"\/gp\/bestsellers\/books\/12379963031\/ref=pd_zg_hrsr_books","name":"Pharmacology"}]},{"rank":24,"ladder":[{"url":"\/gp\/bestsellers\/books\/12386779031\/ref=pd_zg_hrsr_books","name":"Public Health Administration"}]},{"rank":221,"ladder":[{"url":"\/gp\/bestsellers\/books\/12379961031\/ref=pd_zg_hrsr_books","name":"Medicine"}]}],"top_review":"This is the best pharmacology book.It is regularly updated. It is a gold standard for all p\u00e8hysicians and pharmacists.All physicians should have a copy available all the time for quick consultation.The cost is reasonably high for this type of book but it is right considering its full qualities.\n  \nRead more","asin_in_url":"0857114581","description":"The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by health professionals across the world to support confident decision-making at the point of care.\nThe new edition (BNF 85) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.\nExtensive content updates in the BNF 85 edition include:\nNew monographs for:\nAklief\u00ae (trifarotene) for acne vulgaris\nDrovelis\u00ae (drospirenone with estetrol)for hormonal contraception\nDucressa\u00ae (dexamethasone with levofloxacin)for prophylaxis or treatment of postoperative inflammation, or prevention of infection, following cataract surgery\nKerendia\u00ae (finerenone) for chronic kidney disease associated with type 2 diabetes\nMagnesium citrate for treatment and prevention of magnesium deficiency\nNetildex\u00ae (dexamethasone with netilmicin) for local treatment of eye inflammation and bacterial infection\nNettacin\u00ae (netilmicin) for local treatment of eye infection\nSibnayal\u00ae (potassium citrate with potassium bicarbonate) for distal renal tubular acidosis\nTenkasi\u00ae (oritavancin) for acute bacterial skin and skin structure infections\nVydura\u00ae (rimegepant) for treatment or prophylaxis of migraine\nXerava\u00ae (eravacycline) for complicated intra-abdominal infections\nMHRA advice on:\nAnagrelide: risk of thrombosis, including cerebral infarction, if treatment discontinued abruptly\nDenosumab (Prolia\u00ae): should not be used in patients under 18 years due to the risk of serious hypercalcaemia\nDexmedetomidine: clinical trial finds increased risk of mortality in intensive care unit patients aged 65 years or younger\nMetformin hydrochloride: reduced vitamin B12 levels and new advice for monitoring patients at risk\nMethylphenidate hydrochloride long-acting (modified-release) preparations: caution if switching between products due to differences in formulations\nNebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists\nRucaparib (Rubraca\u00ae): withdrawal of third-line treatment indication\nTopiramate (Topamax\u00ae): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure\nOther significant changes include updated guidance on:\nAntibacterials for the prevention of secondary cases of diphtheria, and addition of guidance for the prevention of intra-uterine infection in preterm prelabour rupture of membranes\nContraceptive interactions\nPrescribing of drugs associated with dependence and withdrawal\nCOVID-19 vaccines\nManagement of depression\nDiphtheria vaccine\nManagement of epilepsy\nManagement of gout\nPost-exposure prophylaxis of herpesvirus infections\nHydrocortisone: addition of children\u2019s dosing for adrenal crisis\nManagement of hypertension in patients with type 1 diabetes\nManagement of multiple sclerosis\nObstetrics: preterm labour\nTacrolimus: updated pregnancy, breast-feeding and monitoring advice\nType 1 diabetes: inclusion of continuous glucose monitoring in aims of treatment\nType 2 diabetes: use of non-insulin antidiabetic drugs\nValaciclovir: update to indication and doses in line with UK Health Security Agency recommendations on post-exposure prophylaxis for chickenpox and shingles\nOrder your copy and get:\nUp-to-date information on prescribing, dispensing, and administering medicines\nAuthoritative, independent guidance on best practice enabling you to select safe and effective medicines\nInformation you can trust for quality and reliability\nEverything you need at your fingertips, all in one book","price_upper":231.9,"pricing_str":"","pricing_url":"https:\/\/www.amazon.ae\/gp\/offer-listing\/0857114581?startIndex=0","discount_end":"","manufacturer":"Joint Formulary Committee","max_quantity":30,"price_buybox":-1,"product_name":"BNF 85 (British National Formulary) March 2023","bullet_points":"","is_addon_item":false,"price_initial":0,"pricing_count":4,"reviews_count":23,"sns_discounts":[],"developer_info":[],"lightning_deal":null,"price_shipping":0,"is_prime_pantry":false,"product_details":{"isbn_10":"0857114581","isbn_13":"978-0857114587","language":"English","paperback":"1864 pages","publisher":"Pharmaceutical Press; 85th edition (22 March 2023)","dimensions":"14.8 x 4.5 x 21 cm"},"featured_merchant":[],"is_prime_eligible":false,"parse_status_code":12005,"answered_questions_count":0,"rating_stars_distribution":[{"rating":5,"percentage":80},{"rating":4,"percentage":14},{"rating":3,"percentage":0},{"rating":2,"percentage":0},{"rating":1,"percentage":6}]}